Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

Novo Nordisk saw sales growth for its diabetes and obesity care segment slow in the first half of 2025, confirming investor ...

Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for ...

A woman who lost over two stone in just four months has revealed how she was able to quit weight-loss jabs for good by 'micro ...

A new study suggests that the anti-obesity drug tirzepatide may help reduce the growth of breast cancer linked to obesity.

The number of people taking weight-loss injections is exploding. With more and more men going “on the needle”, here’s what ...

Indian pharmaceutical companies are preparing to launch generic versions of Novo Nordisk's weight-loss drug, semaglutide, potentially reducing its price by up to 80%.

Eli Lilly and Company is gearing up for its second quarter earnings report this Thursday, before the market opens. The pharmaceutical giant has witnessed significant revenue boosts from its ...

Eli Lilly's stock is lagging the S&P 500 since April, potentially allowing a catch-up trade if results impress. Medicare may ...

Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks, Health Canada warns in public advisory.

By Christy Santhosh (Reuters) -Danish drugmaker Novo Nordisk said on Tuesday it has filed 14 new lawsuits in the United ...